Hou D, Yu T. Innovative stroke intervention: Harnessing cerebral dopamine neurotrophic factor. Molecular therapy : the journal of the American Society of Gene Therapy. 2024. doi:10.1016/j.ymthe.2024.10.010
Publications
Bao R, Hutson A, Madabhushi A, et al. Ten challenges and opportunities in computational immuno-oncology. Journal for immunotherapy of cancer. 2024;12(10). doi:10.1136/jitc-2024-009721
Yu C, Natarajan P, Patel AP, et al. Polygenic risk, aspirin and primary prevention of coronary artery disease. European heart journal. Cardiovascular pharmacotherapy. 2024. doi:10.1093/ehjcvp/pvae085
Yu C, Natarajan P, Patel AP, et al. Polygenic risk, aspirin and primary prevention of coronary artery disease. European heart journal. Cardiovascular pharmacotherapy. 2024. doi:10.1093/ehjcvp/pvae085
Gonzalez-Ramos A, Berglind F, Kudláček J, et al. Chemogenetics with PSAM-GlyR decreases excitability and epileptiform activity in epileptic hippocampus. Gene therapy. 2024. doi:10.1038/s41434-024-00493-7
Gonzalez-Ramos A, Berglind F, Kudláček J, et al. Chemogenetics with PSAM-GlyR decreases excitability and epileptiform activity in epileptic hippocampus. Gene therapy. 2024. doi:10.1038/s41434-024-00493-7
Mangani D, Subramanian A, Huang L, et al. Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell state. Immunity. 2024. doi:10.1016/j.immuni.2024.09.017
Uroz M, Stoddard AE, Sutherland BP, et al. Differential stiffness between brain vasculature and parenchyma promotes metastatic infiltration through vessel co-option. Nature cell biology. 2024. doi:10.1038/s41556-024-01532-6
Laak AT, Hillig RC, Ferrara SJ, et al. Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran -Active KAT6AB Inhibitor. Journal of medicinal chemistry. 2024. doi:10.1021/acs.jmedchem.4c01709
Kennedy C, Doyle R, Gough O, et al. A Novel Role for FERM Domain-Containing Protein 3 (FRMD3) in CKD. Kidney360. 2024. doi:10.34067/KID.0000000602